Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial

Robert Rosenstein, David Parra

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish
JournalThe Lancet
Volume374
Issue number9683
DOIs
StatePublished - Jul 10 2009

Fingerprint

Drug Dose Response Relationship
Fluorobenzenes
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pyrimidines
Sulfonamides
Risk Reduction Behavior
C-Reactive Protein
LDL Cholesterol
Research Design
Cardiovascular Diseases
Rosuvastatin Calcium

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial. / Rosenstein, Robert; Parra, David.

In: The Lancet, Vol. 374, No. 9683, 10.07.2009.

Research output: Contribution to journalArticle

Rosenstein, Robert ; Parra, David. / Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial. In: The Lancet. 2009 ; Vol. 374, No. 9683.
@article{673267551f844fdc98242f00247ebe3c,
title = "Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial",
author = "Robert Rosenstein and David Parra",
year = "2009",
month = "7",
day = "10",
doi = "10.1016/S0140-6736(09)61230-7",
language = "English",
volume = "374",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9683",

}

TY - JOUR

T1 - Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial

AU - Rosenstein, Robert

AU - Parra, David

PY - 2009/7/10

Y1 - 2009/7/10

UR - http://www.scopus.com/inward/record.url?scp=67649446960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649446960&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(09)61230-7

DO - 10.1016/S0140-6736(09)61230-7

M3 - Article

VL - 374

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9683

ER -